WHO issues these guidelines regarding Omicron

Multiple countries have already imposed travel bans

995
WHO

Last Updated on December 3, 2021 by The Health Master

WHO issues these guidelines regarding Omicron

Calling on countries to refrain from imposing blanket travel bans amid rising Omicron fears, the World Health Organisation (WHO) has said that such measures will not prevent international spread but will place a heavy burden on lives and livelihoods.

Multiple countries have already imposed travel bans, with most targeting South African nations, where the new variant of the coronavirus was first reported.

When it comes to travel measures, the body has asked countries to apply an ‘evidence-informed and risk-based approach” to any travel measures, including possible screening or quarantining of international passengers.

The WHO on November 26, 2021, designated variant ‘B.1.1.529‘ as a variant of concern. WHO had noted that the Omicron variant has a large number of mutations, some of which happen to be ‘concerning’, it says.

WHO advisory to countries:

1. Continue applying ‘evidence-informed and risk-based’ approach when implementing travel measures in accordance with the International Health Regulations (IHR), including the latest Temporary Recommendations issued by the WHO Director-General on October 26th following the 9th Emergency Committee for C-19.

2. National authorities in countries of departure, transit and arrival may apply a multi-layered risk mitigation approach to potentially delay and/or reduce the exportation or importation of the new variant. Such measures may include screening of passengers prior to travelling and/or upon arrival, including via the use of C-19 testing or the application of quarantine to international travellers. These measures, nonetheless, need to be defined following a thorough risk assessment process.

3. Blanket travel bans will not prevent the international spread, and they place a heavy burden on lives and livelihoods. Blanket bans have the potential to adversely impact global health efforts during a pandemic by disincentivizing countries to report and share epidemiological and sequencing data.

4. All countries should ensure that the measures are regularly reviewed and updated when new evidence becomes available on the epidemiological and clinical characteristics of Omicron or any other VOC.

5. Any travel-related risk mitigation measures should be part of an overall national response strategy. For example, enhancing surveillance and sequencing efforts to better understand circulating SARS-CoV-2 variants, not only among travellers, but also within the community

6. Essential international travel –including travel for emergency and humanitarian missions, travel of essential personnel, repatriations and cargo transport of essential supplies–should continue to be prioritized at all times during the C-19 pandemic.

7. In addition, all travellers should be reminded to remain vigilant for signs and symptoms of C-19, to get vaccinated when it is their turn and to adhere to public health and social measures at all times and regardless of vaccination status.

8. Persons who are unwell, or who have not been fully vaccinated or do not have proof of previous C-19 infection and are at increased risk of developing severe disease and dying, including people 60 years of age or older or those with comorbidities that present increased risk of severe C-19 (e.g. heart disease, cancer and diabetes) should be advised to postpone travel to areas with community transmission.

9. Since the beginning of the SARS-CoV-2 outbreak, WHO has been monitoring the international travel measures implemented by countries and sharing this information with National IHR Focal Points via the Event Information Site (EIS). As of 28 November 2021, 56 countries were reportedly implementing travel measures aimed at potentially delaying the importation of the new variant.

10. Countries should continue sharing their public health rationale and relevant scientific information for additional health measures with WHO under the provisions of Article 43 of the IHR (2005).

“I am equally concerned that several member states are introducing blunt, blanket measures that are not evidence-based or effective on their own, and which will only worsen inequities,” WHO Director-General Tedros Adhanom Ghebreyesus said.

Govt amends Drugs Rules on Import Licence and registration certificate

Govt is considering revising the DPCO to encourage drug innovation

Govt may impose anti-dumping duty on Pharma API from China

Toxic gas leak in Parawada Pharma City

Govt is considering revising the DPCO to encourage drug innovation

6 arrested for Codeine cough syrup smuggling to Bangladesh

Andhra Pradesh: Doctor gets patent for Plasma Therapy Kit

Retired Pharmacists to motivate serving Pharmacists

No need to panic over new Covid-19 variant: ICMR

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner